PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

2b or NOT to be, page-10

  1. 118 Posts.
    lightbulb Created with Sketch. 10
    Yes- Lots of prior art in horse and dog on top of human studies starting in the 80s (I think) in treating osteoarthritis. There is also a generic PPS approved in EEC for dog use which claims it is identical chemical to Cartrophen. DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.